t(KMT2A;v)
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | t(KMT2A;v) | Acute Lymphoblastic Leukemia | Revumenib | |
| FDA (2) | t(KMT2A;v) | Acute Myeloid Leukemia | Revumenib | |
| FDA (2) | t(KMT2A;v) | Burkitt Lymphoma | Revumenib | |
| FDA (2) | t(KMT2A;v) | Acute Leukemias of Ambiguous Lineage | Revumenib |